RN7SKP13

Across TCGA pan-cancer cohorts, RN7SKP13 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RN7SKP13 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SKP13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP13 expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

KIRC, HNSC, and DLBC are the cancer types where RN7SKP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.016	0.806	<.001	72	view →
HNSC	DFS	Tertile	All	0.291	0.630	.001	69	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
ESCA	OS	Tertile	II,III,IV	1.000	0.417	.030	36	view →
STAD	OS	Tertile	IV	1.000	0.299	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RN7SKP13–KIRC (OS)

Open the KIRC breakdown →